Investors Sell UnitedHealth Group (UNH) on Strength (UNH)

Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Tuesday. $117.95 million flowed into the stock on the tick-up and $240.08 million flowed out of the stock on the tick-down, for a money net flow of $122.13 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 6th highest net out-flow for the day. UnitedHealth Group traded up $2.53 for the day and closed at $263.54

Several equities research analysts recently commented on UNH shares. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price on the stock in a report on Sunday, July 15th. Goldman Sachs Group reiterated a “buy” rating and set a $277.00 target price on shares of UnitedHealth Group in a report on Tuesday, July 17th. Royal Bank of Canada raised their target price on UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Citigroup raised their target price on UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Finally, Morgan Stanley raised their target price on UnitedHealth Group from $277.00 to $278.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. One research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $289.41.

The company has a quick ratio of 0.75, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $251.22 billion, a PE ratio of 26.17, a P/E/G ratio of 1.50 and a beta of 0.78.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. During the same period in the previous year, the business earned $2.66 EPS. UnitedHealth Group’s revenue for the quarter was up 12.4% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Inc will post 12.81 EPS for the current year.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, August 8th. The stock was sold at an average price of $258.83, for a total value of $2,588,300.00. Following the sale, the director now owns 77,172 shares in the company, valued at $19,974,428.76. The disclosure for this sale can be found here. Insiders have sold a total of 79,568 shares of company stock worth $21,128,177 over the last 90 days. 0.87% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of the business. FMR LLC grew its position in shares of UnitedHealth Group by 5.1% in the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after acquiring an additional 2,981,233 shares in the last quarter. Vontobel Asset Management Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $404,980,000. Bank of Montreal Can acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $381,555,000. Janus Henderson Group PLC grew its position in shares of UnitedHealth Group by 61.7% in the 2nd quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock worth $864,869,000 after acquiring an additional 1,345,083 shares in the last quarter. Finally, Chevy Chase Trust Holdings Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $248,898,000. Institutional investors own 85.43% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Investors Sell UnitedHealth Group (UNH) on Strength (UNH)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/11/06/investors-sell-unitedhealth-group-unh-on-strength-unh-2.html.

About UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: How to interpret a stock’s beta number

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply